Suchergebnisse - "Rugo, Hope S"

PubPharm (711)

1

Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer : results from the dose expansion groups of an open-label, phase 1b study

enthalten in: The Lancet. Oncology | 2024

von Layman, R. | Han, H. | Rugo, H. | +9

2

Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

enthalten in: NPJ breast cancer | 2024

von Hurvitz, S. | Bardia, A. | Punie, K. | +8

3

Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant : ASCO Rapid Recommendation Update

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Burstein, H. | DeMichele, A. | Fallowfield, L. | +31

4

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ríos-Hoyo, A. | Cobain, E. | Huppert, L. | +6

5

TROPION-Breast01 : Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer

enthalten in: Future oncology (London, England) | 2024

von Bardia, A. | Jhaveri, K. | Kalinsky, K. | +21

6

Treatment outcomes in older patients with metastatic breast cancer receiving palbociclib plus an aromatase inhibitor : a plain language summary

enthalten in: Future oncology (London, England) | 2024

von Brufsky, A. | Liu, X. | Li, B. | +4

7

A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative)

enthalten in: Future oncology (London, England) | 2024

von Rugo, H. | Bardia, A. | Marmé, F. | +4

8

Prolonging the lives of African-Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice : a plain language summary of a real-world database study

enthalten in: Future oncology (London, England) | 2024

von Rugo, H. | Liu, X. | Li, B. | +5

9

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer : Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Rastogi, P. | O'Shaughnessy, J. | Martin, M. | +20

10

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Slamon, D. | Diéras, V. | Rugo, H. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[72]